Search Query :
3GXM
Crystal structure of acid-beta-glucosidase at ph 4.5, phosphate crystallization condition Deposition Author(s): Lieberman, R.L.
Date: 2009-04-02 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 3GXM_A , 3GXM_B , 3GXM_C , 3GXM_D
3GXN
Crystal structure of apo alpha-galactosidase a at ph 4.5 Deposition Author(s): Lieberman, R.L.
Date: 2009-04-02 Method: X-RAY DIFFRACTION Resolution: 3.01 Å Organism(s): Homo Sapiens Sequences Data: 3GXN_A , 3GXN_B
3GXP
Crystal structure of acid-alpha-galactosidase a complexed with galactose at ph 4.5 Deposition Author(s): Lieberman, R.L.
Date: 2009-04-02 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 3GXP_A , 3GXP_B
3GXT
Crystal structure of alpha-galactosidase a at ph 4.5 complexed with 1-deoxygalactonijirimycin Deposition Author(s): Lieberman, R.L.
Date: 2009-04-02 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Homo Sapiens Sequences Data: 3GXT_A , 3GXT_B
3NN8
Crystal structure of engineered antibody fragment based on 3d5 Deposition Author(s): Culver, J.A. , Drury, J.E. , Lieberman, R.L. , Maynard, J.A. , Pai, J.
Date: 2010-06-23 Method: X-RAY DIFFRACTION Resolution: 3.1 Å Organism(s): Mus Musculus Sequences Data: 3NN8_A , 3NN8_B , 3NN8_C , 3NN8_D
3RIK
The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease Deposition Author(s): Lieberman, R.L. , Orwig, S.D.
Date: 2011-04-13 Method: X-RAY DIFFRACTION Resolution: 2.48 Å Organism(s): Homo Sapiens Sequences Data: 3RIK_A , 3RIK_B , 3RIK_C , 3RIK_D
3RIL
The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease Deposition Author(s): Lieberman, R.L. , Orwig, S.D.
Date: 2011-04-13 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 3RIL_A , 3RIL_B , 3RIL_C , 3RIL_D
4NKD
Crystal structure of engineered anti-ee scfv antibody fragment Deposition Author(s): Etzminger, K. , Heaner Jr., D. , Hyun, J. , Jain, A. , Johnson, J.L. , Kalyoncu, S. , Lieberman, R.L. , Maynard, J.A. , Molares, I.A. , Pai, J.C. , Truskett, T.M.
Date: 2013-11-12 Method: X-RAY DIFFRACTION Resolution: 3.303 Å Organism(s): Mus Musculus Sequences Data: 4NKD_A , 4NKD_B , 4NKD_C , 4NKD_D
4NKM
Crystal structure of engineered anti-ee scfv antibody fragment Deposition Author(s): Etzminger, K. , Heaner Jr., D. , Hyun, J. , Jain, A. , Johnson, J.L. , Kalyoncu, S. , Lieberman, R.L. , Maynard, J.A. , Molares, I.A. , Pai, J.C. , Truskett, T.M.
Date: 2013-11-12 Method: X-RAY DIFFRACTION Resolution: 3.71 Å Organism(s): Mus Musculus Sequences Data: 4NKM_A , 4NKM_B , 4NKM_C , 4NKM_D
4NKO
Crystal structure of engineered anti-ee scfv antibody fragment Deposition Author(s): Etzminger, K. , Heaner Jr., D. , Hyun, J. , Jain, A. , Johnson, J.L. , Kalyoncu, S. , Lieberman, R.L. , Maynard, J.A. , Molares, I.A. , Pai, J.C. , Truskett, T.M.
Date: 2013-11-12 Method: X-RAY DIFFRACTION Resolution: 3.496 Å Organism(s): Mus Musculus Sequences Data: 4NKO_A , 4NKO_B , 4NKO_C